Brief: FDA Approves Sientra’s Low Plus Profile Projection Breast Implant
06/07/2022 14:03
July 6 (Reuters) - Sientra Inc SIEN.O :
* FDA APPROVES SIENTRA’S LOW PLUS PROFILE PROJECTION BREAST
IMPLANT
* SIENTRA INC- PRODUCT WILL BE COMMERCIALLY AVAILABLE FOR
BOARD-CERTIFIED AND BOARD-ELIGIBLE PLASTIC SURGEONS IN UNITED
STATES IN LATE JULY 2022
Source text for Eikon: ID:nGNX4Y65j1
Further company coverage: SIEN.O
Recent news on Project Sage Oldco
See all newsBrief: Sientra Says Bankruptcy Court Entered An Order Approving Dip Credit Agreement On An Interim Basis On Feb 14
Brief: Sientra To Pursue Strategic Sale Of Its Business Through Voluntary Chapter 11 Process
U.S. STOCKS ON THE MOVE-premarket
Brief: Sientra Files For Voluntary Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Sientra Says Co Entered Into Amendment No. 2 To Temporary Waiver And Exchange Agreement And Temporary Amendment To Facility Agreement